MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Infra-red 3D digital imaging, tomography and spectroscopy technology.

US based innovative start-up company is developing a unique 3D infrared digital imaging device for the early detection of breast cancer.

Full description

The company aims to develop this technology into a hand held unit for use at home so to enable the patient to check periodically his status in the interval between the regular check-up visit to the hospital or physician's facility. The technology compares breast skin and tissue images against a library of normal images in order to detect any abnormalities.

Development status

Early Stage

Type of business relationship sought

Our clients are seeking US mid-sized partners with commercialization and marketing expertise to develop this technology further and possibly launch it. They would ideally be interested in a research and development agreement to fund the development of the device further.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
ShareVault
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us